 Mahindra Logistics Ltd reports consolidated loss of Rs. 10.35 crores in Q2FY26
Mahindra Logistics Ltd reports consolidated loss of Rs. 10.35 crores in Q2FY26 Indian Oil Corporation Ltd consolidated Q2 FY2025-26 net profit climbs to Rs. 7817.55 crores
Indian Oil Corporation Ltd consolidated Q2 FY2025-26 net profit climbs to Rs. 7817.55 crores Jubilant Ingrevia Ltd posts Rs. 69.47 crores consolidated PAT in Q2FY26
Jubilant Ingrevia Ltd posts Rs. 69.47 crores consolidated PAT in Q2FY26 Raghav Productivity Enhancers Ltd Q2FY26 consolidated profit at Rs. 13.84 crores
Raghav Productivity Enhancers Ltd Q2FY26 consolidated profit at Rs. 13.84 crores Canara Robeco Asset Management Company Ltd Q2FY26 PAT drops to Rs. 48.71 crores
Canara Robeco Asset Management Company Ltd Q2FY26 PAT drops to Rs. 48.71 crores 
              The equity shares of Parabolic Drugs Ltd (BSE Scrip Code: 533211) was listed and admitted to dealings on the Bombay Stock Exchange (BSE) and National Stock Exchange (NSE) from July 1, 2010.
The stock opened in BSE for the day at Rs 76, up by Rs.1 as compared to the IPO price of Rs 75 per share.
The stock was last trading in BSE at Rs.67.40, down by Rs.7.60 or 10.13%. The stock hit an intraday high of Rs.79 and low of Rs.65.30.
The total traded quantity was 5379841 at a weighted average price of Rs 69.01.